Main
>
ONCOLOGY (**)
>
Skin Cancer>Melanoma>MET>BRAF+***
>
Treatment
>
USA. G. AterolizuMAb+Cobimetinib+
>
(*) USA Approval Date: 2020. 07.30
(*) USA Approval Date: 2020. 07.30's products
This section has no products